These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29792354)

  • 21. A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation.
    Artemov A; Aliper A; Korzinkin M; Lezhnina K; Jellen L; Zhukov N; Roumiantsev S; Gaifullin N; Zhavoronkov A; Borisov N; Buzdin A
    Oncotarget; 2015 Oct; 6(30):29347-56. PubMed ID: 26320181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optogenetics in cancer drug discovery.
    Kiełbus M; Czapiński J; Odrzywolski A; Stasiak G; Szymańska K; Kałafut J; Kos M; Giannopoulos K; Stepulak A; Rivero-Müller A
    Expert Opin Drug Discov; 2018 May; 13(5):459-472. PubMed ID: 29447015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation.
    Alymani NA; Smith MD; Williams DJ; Petty RD
    Eur J Cancer; 2010 Mar; 46(5):869-79. PubMed ID: 20138504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 25. Pairing Cancer Biomarkers to Biomedicine.
    Shin SH; Dong Z
    EBioMedicine; 2017 Nov; 25():1-2. PubMed ID: 29113773
    [No Abstract]   [Full Text] [Related]  

  • 26. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
    Xiao J; Glasgow E; Agarwal S
    Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chasing the personalized medicine dream through biomarker validation in colorectal cancer.
    Patil H; Saxena SG; Barrow CJ; Kanwar JR; Kapat A; Kanwar RK
    Drug Discov Today; 2017 Jan; 22(1):111-119. PubMed ID: 27693431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized medicine in oncology: the future is now.
    Schilsky RL
    Nat Rev Drug Discov; 2010 May; 9(5):363-6. PubMed ID: 20431568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic Natural Products as an Approach Towards the Development of Therapeutic Agents for Precision Medicine.
    Rijo P
    Curr Pharm Des; 2018; 24(36):4205-4206. PubMed ID: 30821216
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeted approaches to childhood cancer: progress in drug discovery and development.
    Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
    Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Precision medicine from experimental to clinical applications in oncology].
    Normanno N
    Recenti Prog Med; 2015 Dec; 106(12):597-600. PubMed ID: 26780068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing Clinical Prediction Models: Pushing the Needle Towards Precision Pharmacotherapy.
    Dorajoo SR; Chan A
    Clin Pharmacol Ther; 2018 Feb; 103(2):180-183. PubMed ID: 28722146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for modern biomarker and drug development in oncology.
    Smith AD; Roda D; Yap TA
    J Hematol Oncol; 2014 Oct; 7():70. PubMed ID: 25277503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response.
    Brackman DJ; Giacomini KM
    Clin Pharmacol Ther; 2018 Feb; 103(2):233-242. PubMed ID: 29023674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial Intelligence and Cancer Drug Development.
    Yang F; Darsey JA; Ghosh A; Li HY; Yang MQ; Wang S
    Recent Pat Anticancer Drug Discov; 2022; 17(1):2-8. PubMed ID: 34323201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network and systems biology: essential steps in virtualising drug discovery and development.
    Wierling C; Kessler T; Ogilvie LA; Lange BM; Yaspo ML; Lehrach H
    Drug Discov Today Technol; 2015 Aug; 15():33-40. PubMed ID: 26464088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming cancer drug discovery with Big Data and AI.
    Workman P; Antolin AA; Al-Lazikani B
    Expert Opin Drug Discov; 2019 Nov; 14(11):1089-1095. PubMed ID: 31284790
    [No Abstract]   [Full Text] [Related]  

  • 38. Structure-based Design on Anticancer Drug Discovery.
    Zhong HA
    Curr Top Med Chem; 2020; 20(10):813-814. PubMed ID: 32463006
    [No Abstract]   [Full Text] [Related]  

  • 39. Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Kholmanskikh Van Criekingen O; Koole S; Thomas DM; Gelderblom H
    Cancer Cell; 2024 Jun; 42(6):923-929. PubMed ID: 38861927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving the goals of effective, safe, and individualized cancer care.
    Roberts SA; Karnes EK; Allen JD; Benner JS; Sigal EV; McClellan M
    Clin Cancer Res; 2011 Nov; 17(21):6632-3. PubMed ID: 22046023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.